Considering that SARS-CoV-2 possesses countermeasures to block IFN activity,6 and that STING can function via IFN-independent mechanisms such as translation inhibition59 and autophagy,60 we reason that STING agonist-based therapies may offer new opportunities to treat COVID-19. This evidence concerns the gene STING1 and COVID-19.